667
Participants
Start Date
September 13, 2021
Primary Completion Date
March 24, 2023
Study Completion Date
May 12, 2023
Oral semaglutide
Participants will receive a daily dose of oral semaglutide.
Placebo (semaglutide)
Oral placebo (semaglutide) once daily. Planned treatment duration will be 68 weeks.
Hvidovre Hospital Endokrinologisk forsknings afsnit 159, Hvidovre
Center for Klinisk Metabolisk Forskning, Hellerup
Sjællands Universitetshospital, Køge
Diabetes Zentrum Wandsbek Berufsausuebungsgemeinschaft GbR, Hamburg
Washington Cntr Weight Mgmt, Arlington
RED-Institut für medizinische Forschung und Fortbildung GmbH, Oldenburg in Holstein
Accellacare, Wilmington
Les Hopitaux de Chartres-Hopital Louis Pasteur, Le Coudray
Clinical Trial Res Assoc,Inc, Plantation
Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque-2, Pessac
Univ of Alabama Birmingham, Birmingham
StudyCor, Jyväskylä
Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec-1, Saint-Herblain
InnoDiab Forschung GmbH, Essen
Midwest Inst For Clin Res, Indianapolis
Seinäjoen keskussairaala, Seinäjoki
Praxis Dr. med. Wenzl-Bauer, Rehlingen-Siersburg
Centre de Recherche Clinique Portes Du Sud, Vénissieux
Erlinger, Stuttgart
Fondation Hôtel-Dieu, Le Creusot
Groupe Sos Sante-Hopital Le Creusot-Hotel Dieu-2, Le Creusot
Velocity Clinical Res-Dallas, Dallas
Zentrum für klinische Studien Allgäu Oberschwaben, Wangen
Velocity Clin Res Wstlke, Los Angeles
East West Med Res Inst, Honolulu
Capital Clin Res Ctr,LLC, Olympia
National Medical Research Center of Endocrinology, Moscow
Endocrinological Dispensary of Department of healthcare ser., Moscow
Federal Bureau for Medical and Social Expertise, Moscow
"LLC Clinic of new technologies in Medicine", Dzerzhinskiy
"Joint Stock Company Polyclinic Complex", Saint Petersburg
Leningrad Regional Clinical Hospital, Saint Petersburg
"Joint Stock Company Medical technologies", Yekaterinburg
Tumen State Medical University, Tyumen
The University of Penn Center, Philadelphia
Selma Medical Associates, Winchester
Ocean West Research Clinic, Surrey
G.A. Research Associates Ltd., Moncton
Nova Scotia Health Authority, Halifax
Wharton Med Clin Trials, Hamilton
Hamilton Med Res Group, Hamilton
Obesity Research Unit, Helsinki
Milek, Hohenmölsen, Hohenmölsen
Chiba University Hospital_Diabetes, Metabolism and Endocrinology, Chiba-shi, Chiba
Suidoubashi Medical Clinic, Chiyoda-ku, Tokyo
Higashi-shinjuku clinic, Tokyo
NZOZ Przychodnia Specjalistyczna Medica, Lublin
Gabinet Leczenia Otylosci i Chorob Dietozaleznych, Bialystok
Centrum Medyczne Pratia Gdynia, Gdynia
Centrum Zdrowia Metabolicznego, Poznan
Centrum Terapii Wspolczesnej, Lodz
Lead Sponsor
Novo Nordisk A/S
INDUSTRY